| 1 |
34508023 | Urine N-acetyl-Ser-Asp-Lys-Pro measurement as a versatile biomarker to assess adherence to angiotensin-converting enzyme inhibitors. | 2022 Feb 1 |
1 |
| 2 |
34347311 | Investigating the antifibrotic potential of N-acetyl seryl-aspartyl-lysyl-proline sequence peptides. | 2021 Nov |
3 |
| 3 |
31889494 | Transforming Non-Selective Angiotensin-Converting Enzyme Inhibitors in C- and N-domain Selective Inhibitors by Using Computational Tools. | 2020 |
1 |
| 4 |
31940798 | Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors. | 2020 Jan 11 |
1 |
| 5 |
29411767 | [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension]. | 2017 |
1 |
| 6 |
26403559 | Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme. | 2015 Sep 25 |
1 |
| 7 |
26656271 | The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis. | 2015 |
1 |
| 8 |
23351021 | Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design. | 2013 Aug |
3 |
| 9 |
22214449 | Structure based drug design of angiotensin-I converting enzyme inhibitors. | 2012 |
1 |
| 10 |
23056909 | Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides. | 2012 |
2 |
| 11 |
17868792 | Rationale for combining blockers of the renin-angiotensin system. | 2007 Sep |
1 |
| 12 |
16413241 | Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans. | 2006 Jan |
1 |
| 13 |
16732017 | Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study. | 2006 Jun |
1 |
| 14 |
12093364 | Ance, a Drosophila angiotensin-converting enzyme homologue, is expressed in imaginal cells during metamorphosis and is regulated by the steroid, 20-hydroxyecdysone. | 2002 Oct 1 |
1 |
| 15 |
11167134 | Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. | 2001 Jan |
1 |
| 16 |
10805521 | Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography. | 2000 Apr 10 |
2 |
| 17 |
10856278 | Angiotensin I-converting enzyme isoforms (high and low molecular weight) in urine of premature and full-term infants. | 2000 Jun |
2 |
| 18 |
7876104 | The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. | 1995 Feb 24 |
1 |